Asset Allocation

As of November 30, 2025.
Type % Net
Cash 1.05%
Stock 23.71%
Bond 71.74%
Convertible 0.00%
Preferred 2.55%
Other 0.95%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.69%    % Emerging Markets: 0.26%    % Unidentified Markets: 1.05%

Americas 93.80%
93.69%
Canada 82.92%
United States 10.77%
0.11%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.67%
United Kingdom 2.35%
2.17%
Denmark 0.00%
France 0.63%
Germany 0.01%
Ireland 0.19%
Italy 0.18%
Netherlands 0.41%
Sweden 0.73%
Switzerland 0.02%
0.14%
Poland 0.14%
0.01%
Israel 0.01%
Greater Asia 0.49%
Japan 0.36%
0.03%
Australia 0.02%
0.10%
Singapore 0.10%
0.00%
Unidentified Region 1.05%

Bond Credit Quality Exposure

AAA 24.90%
AA 16.25%
A 33.26%
BBB 15.20%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.19%
Not Available 9.20%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
13.32%
Materials
0.23%
Consumer Discretionary
3.86%
Financials
7.20%
Real Estate
2.04%
Sensitive
9.56%
Communication Services
1.12%
Energy
0.00%
Industrials
4.60%
Information Technology
3.84%
Defensive
2.94%
Consumer Staples
1.99%
Health Care
0.55%
Utilities
0.40%
Not Classified
74.18%
Non Classified Equity
0.00%
Not Classified - Non Equity
74.18%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 14.37%
Corporate 46.17%
Securitized 1.48%
Municipal 26.52%
Other 11.45%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.15%
Less than 1 Year
0.15%
Intermediate
63.96%
1 to 3 Years
12.74%
3 to 5 Years
14.09%
5 to 10 Years
37.13%
Long Term
32.30%
10 to 20 Years
11.96%
20 to 30 Years
16.62%
Over 30 Years
3.72%
Other
3.59%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial